Literature DB >> 21484218

Cardiovascular implantable device infections.

George M Viola1, Rabih O Darouiche.   

Abstract

As life expectancy continues to increase and biotechnology advances, the use of cardiovascular implantable devices will continue to rise. Unfortunately, despite modern medical advances, the infection and mortality rates remain excessively elevated. This article reviews the pathophysiology and general concepts of cardiac device-related infections, including the physical and chemical characteristics of the medical device, host response to the medical device, and the microbiologic virulence factors. Infections of the most commonly utilized cardiovascular implantable devices, including cardiovascular implantable electronic devices, bioprosthetic and mechanical valves, ventricular assist devices, total artificial hearts, and coronary artery stents, are reviewed in detail.

Entities:  

Year:  2011        PMID: 21484218     DOI: 10.1007/s11908-011-0187-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  87 in total

Review 1.  Direct stenting.

Authors:  Emanuele Barbato; Jean Marco; William Wijns
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

Review 2.  Left ventricular assist device infections: three case reports and a review of the literature.

Authors:  Kumudhini Sivaratnam; Joan M Duggan
Journal:  ASAIO J       Date:  2002 Jan-Feb       Impact factor: 2.872

3.  Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators.

Authors:  A L Chamis; G E Peterson; C H Cabell; G R Corey; R A Sorrentino; R A Greenfield; T Ryan; L B Reller; V G Fowler
Journal:  Circulation       Date:  2001-08-28       Impact factor: 29.690

4.  Diagnosis and management of infections involving implantable electrophysiologic cardiac devices.

Authors:  J D Chua; B L Wilkoff; I Lee; N Juratli; D L Longworth; S M Gordon
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

5.  Active infective endocarditis: management and risk analysis of hospital death from 24 years' experience.

Authors:  Makoto Hanai; Kazuhiro Hashimoto; Kenoh Mashiko; Tatsuumi Sasaki; Yoshimasa Sakamoto; Kazuaki Shiratori; Kei Tanaka; Michio Yoshitake; Hirokuni Naganuma; Gen Shinohara
Journal:  Circ J       Date:  2008-11-04       Impact factor: 2.993

Review 6.  Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications.

Authors:  Silviu Itescu; Ranjit John
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

7.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

8.  Risk factors for mortality in patients with cardiac device-related infection.

Authors:  Timir S Baman; Sanjaya K Gupta; Javier A Valle; Elina Yamada
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-13

9.  LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection.

Authors:  Robert S Poston; Shahid Husain; Damian Sorce; Ellieen Stanford; Shimon Kusne; Margaret Wagener; Bartley P Griffith; Robert L Kormos
Journal:  J Heart Lung Transplant       Date:  2003-08       Impact factor: 10.247

10.  Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.

Authors:  Walter E Pae; John M Connell; Amos Adelowo; John P Boehmer; Reiner Korfer; Aly El-Banayosy; Roland Hetzer; Mario Vigano; Alain Pavie
Journal:  J Heart Lung Transplant       Date:  2007-03       Impact factor: 10.247

View more
  3 in total

1.  Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms.

Authors:  Rui Huang; Cheng-Hsuan Li; Roberto Cao-Milán; Luke D He; Jessa Marie Makabenta; Xianzhi Zhang; Erlei Yu; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2020-06-08       Impact factor: 15.419

Review 2.  Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices.

Authors:  Mohankandhasamy Ramasamy; Jintae Lee
Journal:  Biomed Res Int       Date:  2016-10-31       Impact factor: 3.411

Review 3.  Antibacterial Designs for Implantable Medical Devices: Evolutions and Challenges.

Authors:  Huiliang Cao; Shichong Qiao; Hui Qin; Klaus D Jandt
Journal:  J Funct Biomater       Date:  2022-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.